Aims

Campaign to eliminate HPV and cervical cancer in Sweden

Cervical cancer is preventable and also curable if detected early. Therefore, it is also possible to achieve an elimination of the cancer by efficient HPV-vaccination, screening and treatment. In younger cohorts born 1999 and later, the HPV-vaccination is included in the Swedish school vaccination program with a coverage above 80%. Women in Sweden born 1994-1999 have less vaccination coverage and are therefore invited for free HPV-vaccination. The aim with the campaign is to increase the HPV-vaccination coverage for young women in order to eliminate cervical cancer.

In 2018 the World Health Organization announced a call for global elimination of cervical cancer:

“It is preventable. It is treatable. It is time to eliminate it”.
“Det går att förebygga. Det går att behandla. Det är dags att utrota det.”

Kampanj för utrotning av HPV och livmoderhalscancer

Alla kvinnor födda 1994-1999 erbjuds kostnadsfri vaccination mot HPV med början den 4 oktober 2021.

⇒ Information till Dig som erbjuds HPV-vaccination

⇒ Information till medarbetare och vaccinatörerBild_utrota_HPV-Vacc

The International HPV Reference Center

The International Human Papillomavirus (HPV) Reference Center confirms DNA sequences of novel HPV types after the whole genomes have been cloned, assigns HPV type numbers, deposits and maintains the reference clones, as well as distributes samples of the reference material for research use (as far as allowed by the MTAs with the clone owners).

The International HPV Reference Center (de Villiers et al.,2004Bernard et al.,2010) was originally established at the German Cancer Research Center in Heidelberg in 1985 and was run under the leadership of Dr. Ethel-Michele deVilliers until 2012. In 2012, the International HPV Reference Center was transferred to the Karolinska Institutet, under the leadership of Dr. Joakim Dillner.

HPV_reference_clones_transfer

Transfer of the archives of the International HPV Reference Center on 2012-10-18.

From left: Dr. Joakim Dillner, Dr. Ethel-Michele deVilliers.